Gilead Halts 6 Zydelig Trials After Deaths
Gilead Sciences Inc. is halting six clinical trials involving the cancer drug Zydelig after patient deaths occurred, the U.S. Food and Drug Administration said late Monday....To view the full article, register now.
Already a subscriber? Click here to view full article